Pharma Journalist -

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it exercised, and closed on its exclusive option to acquire Potenza…
Read More...

BioArctic AB (publ) announced that BioArctic and its partner AbbVie have received U.S. Federal Trade Commission (FTC) clearance to license BioArctic's alpha-synuclein antibody portfolio…
Read More...

Innovent Biologics, Inc. (Innovent)  and Incyte announced that the companies, through their respective subsidiaries, have entered into a strategic collaboration agreement for three…
Read More...

AMAG Pharmaceuticals announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc., a private biopharmaceutical company. Through this acquisition, AMAG…
Read More...

The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen…
Read More...

Novartis announced that the European Commission (EC) has approved Xolair (omalizumab) prefilled syringe (PFS) for self-administration, allowing patients with severe allergic asthma…
Read More...

Dragonfly Therapeutics announced it has licensed two TriNKET immunotherapy drug candidates to Celgene Corporation and its affiliates for $12m each plus prospective milestones and…
Read More...

Pharmaceutical Product Development, LLC (PPD) is adding significant therapeutic expertise in cardiovascular disease, critical care, endocrinology, metabolism and diabetes to further…
Read More...

Avacta Group plc and LG Chem Life Sciences announced a multi-target collaboration and development agreement. The agreement provides LG Chem with the exclusive rights to develop and…
Read More...

Berkeley Lights, Inc. and Novo Nordisk announced that Novo Nordisk has purchased the Beacon® Optofluidic platform to accelerate workflows in cell line development and to use the…
Read More...